PEMBROLIZUMAB , Placebo to match ly, ENFORTUMAB VEDOTIN
J4G-MC-JZVD
Phase 3 small_molecule active
Quick answer
PEMBROLIZUMAB , Placebo to match ly, ENFORTUMAB VEDOTIN for Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active